(Q37676296)
Statements
Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach (English)
Andrea Foli
8 November 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference